22nd Century Announces $40 Million Common Stock Registered Direct Offering
BUFFALO, N.Y., June 07, 2021 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused
Read more
Cannabis Biotech
